Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function (Q67752621)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1992

Language	Label	Description	Also known as
English	Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function	scientific article published on 01 January 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function (English)

1 reference

10.1016/S0272-6386(12)70204-4

https://api.crossref.org/works/10.1016/S0272-6386(12)70204-4

12 November 2022

membranous glomerulonephritis

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0272-6386(12)70204-4

https://api.crossref.org/works/10.1016/S0272-6386(12)70204-4

12 November 2022

2

object named as

M. West

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739084

12 November 2022

author name string

K. Jindal

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739084

12 November 2022

R. Bear

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739084

12 November 2022

M. Goldstein

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1739084

12 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1739084

12 November 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:S0272638612702044?httpAccept=text/xml

1 reference

10.1016/S0272-6386(12)70204-4

https://api.crossref.org/works/10.1016/S0272-6386(12)70204-4

12 November 2022

https://api.elsevier.com/content/article/PII:S0272638612702044?httpAccept=text/plain

1 reference

10.1016/S0272-6386(12)70204-4

https://api.crossref.org/works/10.1016/S0272-6386(12)70204-4

12 November 2022

American Journal of Kidney Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

61-67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis and treatment of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Membranous nephropathy: response to steroids and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of cyclophosphamide in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970204-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria

4

1 reference

10.1016/S0272-6386(12)70204-4

https://api.crossref.org/works/10.1016/S0272-6386(12)70204-4

12 November 2022

Identifiers

10.1016/S0272-6386(12)70204-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1739084%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67752621&oldid=1770325141"